Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Could a drug duo help kids with liver disease avoid serious complications?

NCT ID NCT06091345

First seen Mar 28, 2026 · Last updated May 22, 2026 · Updated 8 times

Summary

This study looked at whether giving two drugs together—midodrine and albumin—works better than midodrine alone to prevent serious liver-related problems in children with cirrhosis and fluid buildup in the belly (ascites). The trial involved 61 children and aimed to see if the combo could reduce complications like kidney injury, low sodium, and confusion. The goal is to help these children stay healthier and potentially reach liver transplant in better condition.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LIVER CIRRHOSIS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Institute of Liver & Biliary Sciences (ILBS)

    New Delhi, National Capital Territory of Delhi, 110 070, India

Conditions

Explore the condition pages connected to this study.